BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://github.com/derhansen/sf_event_mgt
METHOD:PUBLISH
BEGIN:VEVENT
UID:144-96@www.leopoldina.org
CLASS: PUBLIC
SUMMARY:Expanding the Scope of CAR T Cell Therapy
DESCRIPTION:The onset of Chimeric Antigen Receptor (CAR) T cell therapy mar
 ks a revolutionary development in the field of immunotherapy, achieving nota
 ble success since its approval in 2017 for treating B cell malignan-cies. D
 esigning a patient's own T cells to specifically identify and eradicate tumo
 r cells has successfully treated individuals with previously incurable hema
 tologic cancers.\n\nWhile CAR T cells are currently predominantly utilized 
 in anti-tumor therapy, their initial conceptualization aimed at a broader o
 bjective of targeting membrane antigens, opening the door to numerous poten
 tial applications. Subsequent studies have explored the application of CAR 
 T cells in non-malignant pathologies, encompassing autoimmune diseases, inf
 ectious diseases, and more recently, conditions such as cardiac fibrosis and
  cellular senescence.\n\nWithin this interdisciplinary discussion, we prese
 nt key findings and implications of CAR-based therapies for non-malignant co
 nditions.\n\nFurther information and Registration\n\nThe interdisciplinary 
 discussion is registered as an training event with the Saxony-Anhalt Medica
 l Association and is aimed at a professionally interested public.\n\nRegist
 ration is closed.\n\nContact\n\nDr. Stefanie Bohley Department Science - Po
 licy - Society E-Mail: stefanie.bohley@leopoldina.org\n\nVideos of the even
 t on YouTube\n\nVideos on the Leopoldina YouTube channel
LOCATION:Halle (Saale)
DTSTAMP:20251112T170935Z
DTSTART:20240407T220000Z
DTEND:20240408T220000Z
END:VEVENT
END:VCALENDAR